TELA - Tela Bio Inc logo

Tela Bio Inc

TELA

TELA Bio develops and markets soft-tissue reconstruction solutions, focusing on hernia repair and abdominal wall reconstruction. Its OviTex products, made from ovine rumen and synthetic materials, are used in various surgical procedures.

⚕️ Healthcare NASDAQ Listed 2019 $ USD
$1,000 invested 5 years ago →$84today

Score Overview

1 Year
Score
Net Growth-6.05%
Net TrendShrank
Net Income Consistency—
Rev Growth-0.46%
Rev TrendShrank
Revenue Consistency—
5 Years
Score4.1
Net Growth-23.75%
Net Trend20%
Net Income Consistency—
Rev Growth171.21%
Rev Trend80%
Revenue Consistency—
All Time
Score
Net Growth-83.63%
Net Trend14%
Net Income Consistency
Rev Growth417.34%
Rev Trend86%
Revenue Consistency

Explore the 2021 public Archive ranking →

Where Tela Bio Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 5 years of fundamentals. TELA does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-30
$ 1.15—
1 Year2025-09-30
$ 1.49-22.82%
5 Years2021-09-30
$ 13.66-91.58%
All Time2019-11-08
$ 13.35-91.39%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 79M-$ 41M$ 30M
2025$ 80M-$ 38M$ 50M
2024$ 69M-$ 37M$ 52M
2023$ 58M-$ 46M$ 46M
2022$ 41M-$ 44M$ 42M
2021$ 29M-$ 33M$ 43M
2020$ 18M-$ 28M$ 74M
IPO2019$ 15M-$ 22M$ 54M
TELA - Tela Bio Inc logo

Tela Bio Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 18M to $ 80M and net income went from -$ 28M to -$ 38M. Revenue increased in 4 of those 5 years; net income in 1.

Tela Bio Inc currently holds a 5-year HDB Score of 4.1 out of 10. How the HDB Score is calculated.

Membership

Explore TELA with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,814 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year · Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies